The abstract begins by outlining the fundamental role of patents in pharmaceutical innovation, highlighting their importance in providing incentives for research and development (R&D) and facilitating access to capital for drug discovery. It then explores recent trends in patenting activity within the pharmaceutical industry, including the rise of biologics, gene therapies, and personalized medicine, which present unique challenges in terms of patentability, regulatory approval, and market exclusivity.
Furthermore, the abstract discusses the impact of the patent regime on access to medicines, particularly in developing countries where affordability and availability of essential drugs are critical concerns. It examines issues such as compulsory licensing, patent pools, and technology transfer agreements, which have emerged as mechanisms to balance the interests of patent holders with public health priorities.
Moreover, the abstract addresses the implications of international trade agreements, such as the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS), on pharmaceutical patenting and access to medicines. It explores debates surrounding the flexibilities and limitations of TRIPS, particularly in the context of public health emergencies such as the COVID-19 pandemic.
Article Details
Unique Paper ID: 162535
Publication Volume & Issue: Volume 10, Issue 10
Page(s): 303 - 309
Article Preview & Download
Share This Article
Join our RMS
Conference Alert
NCSEM 2024
National Conference on Sustainable Engineering and Management - 2024